PN summer web series kicks off in July! Learn more

Acetyl-l-Carnitine Yield Mixed Results for Chemo-Induced Neuropathy

Two clinical trials, one in the US and one in China have been completed on the results of taking Acetyl-l-Carnitine, either during chemotherapy treatments or before treatment. With very different results presented at the American Society of Clinical Oncology annual meeting, there is no clear direction on the use of ALC. Debra Barton, PhD, Mayo Clinic, commented, “Further studies are needed to really understand if ALC should be used to treat peripheral neuropathy.”  READ MORE

Source: TheOncologyReport